Opus Genetics, Inc.: Form 8-K, filed Apr 7, 2026
Filed with the SEC on Apr 7, 2026 and accepted by EDGAR at Apr 7, 2026, 07:01 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-26-013481. Last ingested by Listed: Nov 11, 2026, 00:22 ET. Listed shows no prices and gives no investment advice.